Register for the Zoom stream here: dfci.zoom.us/webinar/regi...
Register for the Zoom stream here: dfci.zoom.us/webinar/regi...
Late abstracts are still being accepted—worth checking out if you’re looking to share your work in a focused, international setting. 🦘🦘🦘
Late abstracts are still being accepted—worth checking out if you’re looking to share your work in a focused, international setting. 🦘🦘🦘
📆 Sep 11, 11:30 AM–8 PM ET, Boston
🔑 Keynote: Nathanael Gray
📝 Registration link: forms.gle/NLUSa51Btrtf...
#TPD #ProteinDegradation #DrugDiscovery #Boston #DFCI
📆 Sep 11, 11:30 AM–8 PM ET, Boston
🔑 Keynote: Nathanael Gray
📝 Registration link: forms.gle/NLUSa51Btrtf...
#TPD #ProteinDegradation #DrugDiscovery #Boston #DFCI
🗓 Date: July 24th
We are very excited to be hosting two fantastic speakers Jonathan Bushman (AMGEN) and Guillaume Lessene (WEHI)
🗓 Date: July 24th
We are very excited to be hosting two fantastic speakers Jonathan Bushman (AMGEN) and Guillaume Lessene (WEHI)
The next FREE Dana-Farber TPD In-Person Event is coming soon!
Join us for an afternoon of cutting-edge science, networking, and community building focused on Targeted Protein Degradation (TPD). Stay tuned for registration and speaker details.
The next FREE Dana-Farber TPD In-Person Event is coming soon!
Join us for an afternoon of cutting-edge science, networking, and community building focused on Targeted Protein Degradation (TPD). Stay tuned for registration and speaker details.
See you on May 15th @ 12PM EST
See you on May 15th @ 12PM EST
Join us to hear about his lab's strategies to target undruggable proteins
Join us to hear about his lab's strategies to target undruggable proteins
@fleurmferguson.bsky.social & Eric Wang - "ZBTB11 Degraders Target Metabolic Vulnerabilities in K-Ras Inhibitor Resistant PDAC"
Slava Ziegler - "Targeting IDO1 by monovalent degraders exploiting the native IDO1 degradation mechanism"
@fleurmferguson.bsky.social & Eric Wang - "ZBTB11 Degraders Target Metabolic Vulnerabilities in K-Ras Inhibitor Resistant PDAC"
Slava Ziegler - "Targeting IDO1 by monovalent degraders exploiting the native IDO1 degradation mechanism"